InsidersTradesSigma
Total declarations
Company
▲ Purchases (8 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Flowers Lee. Officer active across 1 companies, notably HCW Biologics Inc.. In total, 10 filings have been logged. Total volume traded: €634k. The latest transaction was disclosed on 1 December 2021 — Levée d'options. Regulator: SEC (Form 4). The full history is openly available.
Declarations10 total
€5294,285 shares@ €0.12360.0064% mcap0.2% of flow
Common Stock
SEC:0001209191-21-067740·
€5294,285 shares@ €0.12360.0064% mcap0.1% of flow
Common Stock
SEC:0001209191-21-067740:0·
€38,72510,532 shares@ €3.67690.47% mcap12.2% of flow
Common Stock
SEC:0001209191-21-053163·
Ideal exit: 16 May 2022 (T+270)
€27,4657,853 shares@ €3.49730.33% mcap8.7% of flow
Common Stock
SEC:0001209191-21-053170·
Ideal exit: 17 May 2022 (T+270)
€38,72510,532 shares@ €3.67690.47% mcap6.1% of flow
Common Stock
SEC:0001209191-21-053163:0·
Ideal exit: 16 May 2022 (T+270)
€27,4657,853 shares@ €3.49730.33% mcap4.3% of flow
Common Stock
SEC:0001209191-21-053170:0·
Ideal exit: 17 May 2022 (T+270)
€38,35510,532 shares@ €3.64170.47% mcap12.1% of flow
Common Stock
SEC:0001209191-21-053050·
Ideal exit: 16 May 2022 (T+270)
€38,35510,532 shares@ €3.64170.47% mcap6.0% of flow
Common Stock
SEC:0001209191-21-053050:0·
Ideal exit: 16 May 2022 (T+270)
€212,35531,250 shares@ €6.79542.58% mcap66.9% of flow
Common Stock
SEC:0001209191-21-048080·
Ideal exit: 18 Apr 2022 (T+270)
€212,35531,250 shares@ €6.79542.58% mcap33.4% of flow
Common Stock
SEC:0001209191-21-048080:0·
Ideal exit: 18 Apr 2022 (T+270)
10 of 10 declarations
About Flowers Lee
Flowers Lee is a director at HCW Biologics Inc.
